Edward Murphy, MD, MPH

Email Edward

270 Masonic
San Francisco, CA 94118

Visit CTSI Profile

  • Professor, UCSF School of Medicine

Displaying 1 - 117 of 117

  1. Vermeulen M, Swanevelder R, Chowdhury D, Ingram C, Reddy R, Bloch EM, Custer BS, Murphy EL. Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa. Emerg Infect Dis. 2017 Sep; 23(9):1560-1563. View on Pubmed
  2. Tagny CT, Nguefack-Tsague G, Fopa D, Ashu C, Tante E, Ngo Balogog P, Donfack O, Mbanya D, Laperche S, Murphy E. Risk factors for human immunodeficiency virus among blood donors in Cameroon: evidence for the design of an Africa-specific donor history questionnaire. Transfusion. 2017 Aug; 57(8):1912-1921. View on Pubmed
  3. Roubinian NH, Looney MR, Keating S, Kor DJ, Lowell CA, Gajic O, Hubmayr R, Gropper M, Koenigsberg M, Wilson GA, A Matthay M, Toy P, Murphy EL. Differentiating pulmonary transfusion reactions using recipient and transfusion factors. Transfusion. 2017 Jul; 57(7):1684-1690. View on Pubmed
  4. Roubinian N, Brambilla D, Murphy EL. Statistical Caution in Big Data Approaches to Transfusion Medicine Research. JAMA Intern Med. 2017 Apr 24. View on Pubmed
  5. Mehta RH, Leimberger JD, van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D, Fremes S, Duncan A, Soltesz EG, Luber J, Park S, Argenziano M, Murphy E, Marcel R, Kalavrouziotis D, Nagpal D, Bozinovski J, Toller W, Heringlake M, Goodman SG, Levy JH, Harrington RA, Anstrom KJ, Alexander JH. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery. N Engl J Med. 2017 05 25; 376(21):2032-2042. View on Pubmed
  6. Betsem E, Kaidarova Z, Stramer SL, Shaz B, Sayers M, LeParc G, Custer B, Busch MP, Murphy EL. Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010-2012. Emerg Infect Dis. 2017 Feb 15; 23(2). View on Pubmed
  7. Roubinian N, Murphy EL. Adjusting the Focus on Transfusion-associated Circulatory Overload. Anesthesiology. 2017 Jan 10. View on Pubmed
  8. Porto-Ferreira FA, de Almeida-Neto C, Murphy EL, Montebello SC, Nogueira FA, Koga da Silva EM, MacFarland W, Custer B. A randomized trial to evaluate the use of text messaging, letter, and telephone call reminders to improve return of blood donors with reactive serologic tests. Transfusion. 2016 Oct 23. View on Pubmed
  9. Mollenkopf S, Murphy EL. Measuring incidence of HTLV-1: the other human retrovirus. Lancet Infect Dis. 2016 Nov; 16(11):1205-1206. View on Pubmed
  10. Usadi B, Bruhn R, Lin J, Lee TH, Blackburn E, Murphy EL. Telomere Length, Proviral Load and Neurologic Impairment in HTLV-1 and HTLV-2-Infected Subjects. Viruses. 2016; 8(8). View on Pubmed
  11. Hendrickson JE, Roubinian NH, Chowdhury D, Brambilla D, Murphy EL, Wu Y, Ness PM, Gehrie EA, Snyder EL, George Hauser R, Gottschall JL, Kleinman S, Kakaiya R, Strauss RG. Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication. Transfusion. 2016 Jul 26. View on Pubmed
  12. Vo MT, Bruhn R, Kaidarova Z, Custer BS, Murphy EL, Bloch EM. A retrospective analysis of false-positive infectious screening results in blood donors. Transfusion. 2016 Feb; 56(2):457-65. View on Pubmed
  13. Bloch EM, Crookes RL, Hull J, Fawcus S, Gangaram R, Anthony J, Ingram C, Ngcobo S, Croxford J, Creel DV, Murphy EL. The impact of human immunodeficiency virus infection on obstetric hemorrhage and blood transfusion in South Africa. Transfusion. 2015 Jul; 55(7):1675-84. View on Pubmed
  14. Roubinian NH, Looney MR, Kor DJ, Lowell CA, Gajic O, Hubmayr RD, Gropper MA, Koenigsberg M, Wilson GA, Matthay MA, Toy P, Murphy EL. Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions. Transfusion. 2015 Aug; 55(8):1838-46. View on Pubmed
  15. Triulzi D, Gottschall J, Murphy E, Wu Y, Ness P, Kor D, Roubinian N, Fleischmann D, Chowdhury D, Brambilla D. A multicenter study of plasma use in the United States. Transfusion. 2015 Jun; 55(6):1313-9; quiz 1312. View on Pubmed
  16. Toy P, Bacchetti P, Grimes B, Gajic O, Murphy EL, Winters JL, Gropper MA, Hubmayr RD, Matthay MA, Wilson G, Koenigsberg M, Lee DC, Hirschler NV, Lowell CA, Schuller RM, Gandhi MJ, Norris PJ, Mair DC, Sanchez Rosen R, Looney MR. Recipient clinical risk factors predominate in possible transfusion-related acute lung injury. Transfusion. 2015 May; 55(5):947-52. View on Pubmed
  17. van den Berg K, Murphy EL, Pretorius L, Louw VJ. The impact of HIV-associated anaemia on the incidence of red blood cell transfusion: implications for blood services in HIV-endemic countries. Transfus Apher Sci. 2014 Dec; 51(3):10-8. View on Pubmed
  18. Conway BD, Stamou SC, Kouchoukos NT, Lobdell KW, Khabbaz KR, Murphy E, Hagberg RC. Improved clinical outcomes and survival following repair of acute type A aortic dissection in the current era. Interact Cardiovasc Thorac Surg. 2014 Dec; 19(6):971-6. View on Pubmed
  19. Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL. Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion. 2014 Oct; 54(10 Pt 2):2678-86. View on Pubmed
  20. Roubinian NH, Escobar GJ, Liu V, Gardner MN, Carson JL, Kleinman SH, Murphy EL. Decreased red blood cell use and mortality in hospitalized patients. JAMA Intern Med. 2014 Aug; 174(8):1405-7. View on Pubmed
  21. Loureiro P, de Almeida-Neto C, Proietti AB, Capuani L, Gonçalez TT, de Oliveira CD, Leão SC, Lopes MI, Sampaio D, Patavino GM, Ferreira JE, Blatyta PF, Duarte Lopes ME, Mendrone-Junior A, Salles NA, King M, Murphy E, Busch M, Custer B, Sabino EC. [Not Available]. Rev Bras Hematol Hemoter. 2014 Mar-Apr; 36(2):152-8. View on Pubmed
  22. Looney MR, Roubinian N, Gajic O, Gropper MA, Hubmayr RD, Lowell CA, Bacchetti P, Wilson G, Koenigsberg M, Lee DC, Wu P, Grimes B, Norris PJ, Murphy EL, Gandhi MJ, Winters JL, Mair DC, Schuller RM, Hirschler NV, Rosen RS, Matthay MA, Toy P. Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*. Crit Care Med. 2014 Jul; 42(7):1676-87. View on Pubmed
  23. Roubinian NH, Murphy EL, Swain BE, Gardner MN, Liu V, Escobar GJ. Predicting red blood cell transfusion in hospitalized patients: role of hemoglobin level, comorbidities, and illness severity. BMC Health Serv Res. 2014; 14:213. View on Pubmed
  24. Melamed A, Witkover AD, Laydon DJ, Brown R, Ladell K, Miners K, Rowan AG, Gormley N, Price DA, Taylor GP, Murphy EL, Bangham CR. Clonality of HTLV-2 in natural infection. PLoS Pathog. 2014 Mar; 10(3):e1004006. View on Pubmed
  25. Loureiro P, de Almeida-Neto C, Proietti AB, Capuani L, Gonçalez TT, de Oliveira CD, Leão SC, Lopes MI, Sampaio D, Patavino GM, Ferreira JE, Blatyta PF, Lopes ME, Mendrone-Junior A, Salles NA, King M, Murphy E, Busch M, Custer B, Sabino EC. Contribution of the Retrovirus Epidemiology Donor Study (REDS) to research on blood transfusion safety in Brazil. Rev Bras Hematol Hemoter. 2014 Mar; 36(2):152-8. View on Pubmed
  26. Barbeau B, Hiscott J, Bazarbachi A, Carvalho E, Jones K, Martin F, Matsuoka M, Murphy EL, Ratner L, Switzer WM, Watanabe T. Conference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26-30 June 2013, Montreal, Canada. Retrovirology. 2014; 11:19. View on Pubmed
  27. Tagny CT, Mbanya D, Murphy EL, Lefrère JJ, Laperche S. Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test. J Virol Methods. 2014 Apr; 199:119-23. View on Pubmed
  28. Kleinman S, Busch MP, Murphy EL, Shan H, Ness P, Glynn SA. The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes. Transfusion. 2014 Mar; 54(3 Pt 2):942-55. View on Pubmed
  29. Chang YB, Kaidarova Z, Hindes D, Bravo M, Kiely N, Kamel H, Dubay D, Hoose B, Murphy EL. Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009. J Infect Dis. 2014 Feb 15; 209(4):523-31. View on Pubmed
  30. Sabino EC, Ribeiro AL, Salemi VM, Ianni BM, Nastari L, Fernandes F, Di Lorenzo Oliveira C, Antunes AP, Menezes MM, Patavino GM, Capuani L, de Almeida-Neto C, Sachdev V, Carrick DM, Wright D, Kavounis K, Gonzalez TT, Custer B, Busch MP, Murphy EL, Carneiro-Proietti AB. Response to letters regarding article, "Ten-year incidence of Chagas cardiomyopathy among asymptomatic, Trypanosoma cruzi-seropositive former blood donors". Circulation. 2013 Aug 27; 128(9):e137-8. View on Pubmed
  31. Murphy EL. Health outcomes in recipients of blood transfusion - observational studies versus randomized clinical trials. ISBT Sci Ser. 2013 Jun 1; 8(1):172-176. View on Pubmed
  32. Kiss JE, Steele WR, Wright DJ, Mast AE, Carey PM, Murphy EL, Gottschall JL, Simon TL, Cable RG. Laboratory variables for assessing iron deficiency in REDS-II Iron Status Evaluation (RISE) blood donors. Transfusion. 2013 Nov; 53(11):2766-75. View on Pubmed
  33. Sabino EC, Ribeiro AL, Salemi VM, Di Lorenzo Oliveira C, Antunes AP, Menezes MM, Ianni BM, Nastari L, Fernandes F, Patavino GM, Sachdev V, Capuani L, de Almeida-Neto C, Carrick DM, Wright D, Kavounis K, Goncalez TT, Carneiro-Proietti AB, Custer B, Busch MP, Murphy EL. Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors. Circulation. 2013 Mar 12; 127(10):1105-15. View on Pubmed
  34. Terrault NA, Dodge JL, Murphy EL, Tavis JE, Kiss A, Levin TR, Gish RG, Busch MP, Reingold AL, Alter MJ. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013 Mar; 57(3):881-9. View on Pubmed
  35. Murphy EL, Kwaan N, Looney MR, Gajic O, Hubmayr RD, Gropper MA, Koenigsberg M, Wilson G, Matthay M, Bacchetti P, Toy P. Risk factors and outcomes in transfusion-associated circulatory overload. Am J Med. 2013 Apr; 126(4):357.e29-38. View on Pubmed
  36. de Almeida-Neto C, Sabino EC, Liu J, Blatyta PF, Mendrone-Junior A, Salles NA, Leão SC, Wright DJ, Basques FV, Ferreira JE, Busch MP, Murphy EL. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus. Transfusion. 2013 Apr; 53(4):827-34. View on Pubmed
  37. Kouao MD, Dembelé B, N'Goran LK, Konaté S, Bloch E, Murphy EL, Lefrère JJ. Reasons for blood donation deferral in sub-Saharan Africa: experience in Ivory Coast. Transfusion. 2012 Jul; 52(7 Pt 2):1602-6. View on Pubmed
  38. Kleinman S, King MR, Busch MP, Murphy EL, Glynn SA. The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability. Transfus Med Rev. 2012 Oct; 26(4):281-304, 304.e1-2. View on Pubmed
  39. Carneiro-Proietti AB, Sabino EC, Leão S, Salles NA, Loureiro P, Sarr M, Wright D, Busch M, Proietti FA, Murphy EL. Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009. AIDS Res Hum Retroviruses. 2012 Oct; 28(10):1265-72. View on Pubmed
  40. Guiltinan AM, Kaidarova Z, Behan D, Marosi C, Hutching S, Kaiser M, Moore E, Devita D, Murphy EL. Major depression and generalized anxiety disorder among human T-lymphotropic virus types I- and II-infected former blood donors. Transfusion. 2013 Jan; 53(1):60-8. View on Pubmed
  41. van den Berg K, Lam J, Bruhn R, Custer B, Murphy EL. Water administration and the risk of syncope and presyncope during blood donation: a randomized clinical trial. Transfusion. 2012 Dec; 52(12):2577-84. View on Pubmed
  42. Mast AE, Steele WR, Johnson B, Wright DJ, Cable RG, Carey P, Gottschall JL, Kiss JE, Simon TL, Murphy EL. Population-based screening for anemia using first-time blood donors. Am J Hematol. 2012 May; 87(5):496-502. View on Pubmed
  43. Murphy EL, Schlumpf K, Wright DJ, Cable R, Roback J, Sacher R, Busch MP. BMI and obesity in US blood donors: a potential public health role for the blood centre. Public Health Nutr. 2012 Jun; 15(6):964-71. View on Pubmed
  44. Mast AE, Lee TH, Schlumpf KS, Wright DJ, Johnson B, Carrick DM, Cable RG, Kiss JE, Glynn SA, Steele WR, Murphy EL, Sacher R, Busch MP. The impact of HFE mutations on haemoglobin and iron status in individuals experiencing repeated iron loss through blood donation*. Br J Haematol. 2012 Feb; 156(3):388-401. View on Pubmed
  45. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, Wilson G, Koenigsberg M, Lee D, Schuller R, Wu P, Grimes B, Gandhi MJ, Winters JL, Mair D, Hirschler N, Sanchez Rosen R, Matthay MA. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012 Feb 16; 119(7):1757-67. View on Pubmed
  46. Gonçalez TT, Sabino EC, Schlumpf KS, Wright DJ, Leao S, Sampaio D, Takecian PL, Proietti AB, Proitetti AB, Murphy E, Busch M, Custer B. Vasovagal reactions in whole blood donors at three REDS-II blood centers in Brazil. Transfusion. 2012 May; 52(5):1070-8. View on Pubmed
  47. Douceron E, Kaidarova Z, Miyazato P, Matsuoka M, Murphy EL, Mahieux R. HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis. J Infect Dis. 2012 Jan 1; 205(1):82-6. View on Pubmed
  48. Martin F, Bangham CR, Ciminale V, Lairmore MD, Murphy EL, Switzer WM, Mahieux R. Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium. Retrovirology. 2011; 8:86. View on Pubmed
  49. Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, Wright DJ, Sacher RA, Gottschall JL, Tobler LH, Simon TL. Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2012 Apr; 52(4):702-11. View on Pubmed
  50. Tagny CT, Kouao MD, Touré H, Gargouri J, Fazul AS, Ouattara S, Anani L, Othmani H, Feteke L, Dahourou H, Mbensa GO, Molé S, Nébié Y, Mbangue M, Toukam M, Boulahi MO, Andriambelo LV, Rakoto O, Baby M, Yahaya R, Bokilo A, Senyana F, Mbanya D, Shiboski C, Murphy EL, Lefrère JJ. Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors. Transfusion. 2012 Jan; 52(1):134-43. View on Pubmed
  51. de Almeida Neto C, Mendrone A, Custer B, Liu J, Carneiro-Proietti AB, Leão SA, Wright DJ, Murphy EL, Sabino EC. Interdonation intervals and patterns of return among blood donors in Brazil. Transfusion. 2012 Apr; 52(4):722-8. View on Pubmed
  52. Bloch EM, Vermeulen M, Murphy E. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev. 2012 Apr; 26(2):164-80. View on Pubmed
  53. Nébié K, Ouattara S, Sanou M, Kientega Y, Dahourou H, Ky L, Kienou K, Diallo S, Bigirimana F, Fretz C, Murphy EL, Lefrère JJ. Poor procedures and quality control among nonaffiliated blood centers in Burkina Faso: an argument for expanding the reach of the national blood transfusion center. Transfusion. 2011 Jul; 51(7 Pt 2):1613-8. View on Pubmed
  54. Kleinman SH, Triulzi DJ, Murphy EL, Carey PM, Gottschall JL, Roback JD, Carrick D, Mathew S, Wright DJ, Cable R, Ness P, Gajic O, Hubmayr RD, Looney MR, Kakaiya RM. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components. Transfusion. 2011 Oct; 51(10):2078-91. View on Pubmed
  55. Bahrami SH, Guiltinan AM, Schlumpf KS, Scott E, Banks LL, D'Andrea P, Hartman EL, Vij V, Wright DJ, Spencer B, Murphy EL. Donation frequency of blood donors participating in a prospective cohort study of iron status. Transfusion. 2011 Jun; 51(6):1207-12. View on Pubmed
  56. Tagny CT, Mbanya D, Leballais L, Murphy E, Lefrère JJ, Laperche S. Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon. Transfusion. 2011 Jan; 51(1):184-90. View on Pubmed
  57. Rios JA, Schlumpf KS, Kakaiya RM, Triulzi DJ, Roback JD, Kleinman SH, Murphy EL, Gottschall JL, Carey PM. Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure. Transfusion. 2011 Jun; 51(6):1197-206. View on Pubmed
  58. Lefrère JJ, Dahourouh H, Dokekias AE, Kouao MD, Diarra A, Diop S, Tapko JB, Murphy EL, Laperche S, Pillonel J. Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study. Transfusion. 2011 Mar; 51(3):486-92. View on Pubmed
  59. Rice MS, Custer BS, Hindes DA, Hirschler NV, Nguyen KA, Busch MP, Murphy EL. Genetic research in the blood bank: acceptability to Northern California donors. Transfusion. 2010 Sep; 50(9):1951-8. View on Pubmed
  60. Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, Wright DJ, Sacher RA, Gottschall JL, Vij V, Simon TL. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2011 Mar; 51(3):511-22. View on Pubmed
  61. Murphy EL, Fang J, Tu Y, Cable R, Hillyer CD, Sacher R, Triulzi D, Gottschall JL, Busch MP. Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index. J Infect Dis. 2010 Aug 15; 202(4):576-84. View on Pubmed
  62. Biswas HH, Kaidarova Z, Garratty G, Gibble JW, Newman BH, Smith JW, Ziman A, Fridey JL, Sacher RA, Murphy EL. Increased all-cause and cancer mortality in HTLV-II infection. J Acquir Immune Defic Syndr. 2010 Jul; 54(3):290-6. View on Pubmed
  63. Berini CA, Gendler SA, Pascuccio S, Eirin ME, McFarland W, Page K, Carnevali L, Murphy E, Biglione MM. Decreasing trends in HTLV-1/2 but stable HIV-1 infection among replacement donors in Argentina. J Med Virol. 2010 May; 82(5):873-7. View on Pubmed
  64. Goncalez T, Sabino E, Sales N, Chen YH, Chamone D, Busch M, Murphy E, Custer B, McFarland W. Human immunodeficiency virus test-seeking blood donors in a large blood bank in São Paulo, Brazil. Transfusion. 2010 Aug; 50(8):1806-14. View on Pubmed
  65. Mast AE, Schlumpf KS, Wright DJ, Custer B, Spencer B, Murphy EL, Simon TL. Demographic correlates of low hemoglobin deferral among prospective whole blood donors. Transfusion. 2010 Aug; 50(8):1794-802. View on Pubmed
  66. Tobler LH, Bahrami SH, Kaidarova Z, Pitina L, Winkelman VK, Vanderpool SK, Guiltinan AM, Cooper S, Busch MP, Murphy EL. A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME). Transfusion. 2010 Jul; 50(7):1513-23. View on Pubmed
  67. Edgren G, Kamper-Jørgensen M, Eloranta S, Rostgaard K, Custer B, Ullum H, Murphy EL, Busch MP, Reilly M, Melbye M, Hjalgrim H, Nyrén O. Duration of red blood cell storage and survival of transfused patients (CME). Transfusion. 2010 Jun; 50(6):1185-95. View on Pubmed
  68. Gordon SN, Weissman AR, Cecchinato V, Fenizia C, Ma ZM, Lee TH, Zaffiri L, Andresen V, Parks RW, Jones KS, Heraud JM, Ferrari MG, Chung HK, Venzon D, Mahieux R, Murphy EL, Jacobson S, Miller CJ, Ruscetti FW, Franchini G. Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques. J Virol. 2010 Mar; 84(6):3043-58. View on Pubmed
  69. Norris PJ, Hirschkorn DF, DeVita DA, Lee TH, Murphy EL. Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells. Virulence. 2010 Jan-Feb; 1(1):19-28. View on Pubmed
  70. Carneiro-Proietti AB, Sabino EC, Sampaio D, Proietti FA, Gonçalez TT, Oliveira CD, Ferreira JE, Liu J, Custer B, Schreiber GB, Murphy EL, Busch MP. Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008. Transfusion. 2010 Apr; 50(4):918-25. View on Pubmed
  71. Gonçalez TT, Sabino EC, Salles NA, de Almeida-Neto C, Mendrone-Jr A, Dorlhiac-Laccer PE, Liu J, Murphy EL, Schreiber GB. The impact of simple donor education on donor behavioral deferral and infectious disease rates in São Paulo, Brazil. Transfusion. 2010 Apr; 50(4):909-17. View on Pubmed
  72. Remesar MC, Gamba C, Colaianni IF, Puppo M, Sartor PA, Murphy EL, Neilands TB, Ridolfi MA, Leguizamón MS, Kuperman S, Del Pozo AE. Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina. Transfusion. 2009 Nov; 49(11):2352-8. View on Pubmed
  73. Laperche S, Boukatou G, Kouegnigan L, Nébié Y, Boulahi MO, Tagny CT, Yahaya R, Tapko JB, Murphy E, Lefrère JJ. Transfusion safety on the African continent: an international quality control of virus testing in blood banks. Transfusion. 2009 Aug; 49(8):1600-8. View on Pubmed
  74. Murphy EL, McFarland W, Lefrère JJ. Teaching transfusion medicine research methods in the developing world. Transfusion. 2009 Aug; 49(8):1532-4. View on Pubmed
  75. Tagny CT, Diarra A, Yahaya R, Hakizimana M, Nguessan A, Mbensa G, Nébié Y, Dahourou H, Mbanya D, Shiboski C, Murphy E, Lefrère JJ. Characteristics of blood donors and donated blood in sub-Saharan Francophone Africa. Transfusion. 2009 Aug; 49(8):1592-9. View on Pubmed
  76. Halin M, Douceron E, Clerc I, Journo C, Ko NL, Landry S, Murphy EL, Gessain A, Lemasson I, Mesnard JM, Barbeau B, Mahieux R. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. Blood. 2009 Sep 17; 114(12):2427-38. View on Pubmed
  77. Murphy EL, Shaz B, Hillyer CD, Carey P, Custer BS, Hirschler N, Fang J, Schreiber GB. Minority and foreign-born representation among US blood donors: demographics and donation frequency for 2006. Transfusion. 2009 Oct; 49(10):2221-8. View on Pubmed
  78. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion. 2009 Sep; 49(9):1825-35. View on Pubmed
  79. DeVita DA, White MC, Zhao X, Kaidarova Z, Murphy EL. Determinants of subject visit participation in a prospective cohort study of HTLV infection. BMC Med Res Methodol. 2009; 9:19. View on Pubmed
  80. de Almeida Neto C, Murphy EL, McFarland W, Junior AM, Chen S, Chamone DA, Sabino EC. Profile of blood donors with serologic tests reactive for the presence of syphilis in São Paulo, Brazil. Transfusion. 2009 Feb; 49(2):330-6. View on Pubmed
  81. Custer B, Kamel H, Kiely NE, Murphy EL, Busch MP. Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion. 2009 Feb; 49(2):278-88. View on Pubmed
  82. Bartman MT, Kaidarova Z, Hirschkorn D, Sacher RA, Fridey J, Garratty G, Gibble J, Smith JW, Newman B, Yeo AE, Murphy EL. Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood. 2008 Nov 15; 112(10):3995-4002. View on Pubmed
  83. Goncalez TT, Sabino EC, Chen S, Salles NA, Chamone DA, McFarland W, Murphy EL. Knowledge, attitudes and motivations among blood donors in São Paulo, Brazil. AIDS Behav. 2008 Jul; 12(4 Suppl):S39-47. View on Pubmed
  84. Guiltinan AM, Kaidarova Z, Custer B, Orland J, Strollo A, Cyrus S, Busch MP, Murphy EL. Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol. 2008 Mar 15; 167(6):743-50. View on Pubmed
  85. Nguyen DD, Devita DA, Hirschler NV, Murphy EL. Blood donor satisfaction and intention of future donation. Transfusion. 2008 Apr; 48(4):742-8. View on Pubmed
  86. Schlumpf KS, Glynn SA, Schreiber GB, Wright DJ, Randolph Steele W, Tu Y, Hermansen S, Higgins MJ, Garratty G, Murphy EL. Factors influencing donor return. Transfusion. 2008 Feb; 48(2):264-72. View on Pubmed
  87. Madden E, Murphy EL, Custer B. Modeling red cell procurement with both double-red-cell and whole-blood collection and the impact of European travel deferral on units available for transfusion. Transfusion. 2007 Nov; 47(11):2025-37. View on Pubmed
  88. Custer B, Chinn A, Hirschler NV, Busch MP, Murphy EL. The consequences of temporary deferral on future whole blood donation. Transfusion. 2007 Aug; 47(8):1514-23. View on Pubmed
  89. de Almeida Neto C, McFarland W, Murphy EL, Chen S, Nogueira FA, Mendrone A, Salles NA, Chamone DA, Sabino EC. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria. Transfusion. 2007 Apr; 47(4):608-14. View on Pubmed
  90. Beilke MA, Traina-Dorge VL, Sirois M, Bhuiyan A, Murphy EL, Walls JM, Fagan R, Winsor EL, Kissinger PJ. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. Clin Infect Dis. 2007 May 1; 44(9):1229-34. View on Pubmed
  91. Kwaan N, Lee TH, Chafets DM, Nass C, Newman B, Smith J, Garratty G, Murphy EL. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis. 2006 Dec 1; 194(11):1557-64. View on Pubmed
  92. De Castro-Costa CM, Araújo AQ, Barreto MM, Takayanagui OM, Sohler MP, da Silva EL, de Paula SM, Ishak R, Ribas JG, Rovirosa LC, Carton H, Gotuzzo E, Hall WW, Montano S, Murphy EL, Oger J, Remondegui C, Taylor GP. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses. 2006 Oct; 22(10):931-5. View on Pubmed
  93. Reich P, Roberts P, Laabs N, Chinn A, McEvoy P, Hirschler N, Murphy EL. A randomized trial of blood donor recruitment strategies. Transfusion. 2006 Jul; 46(7):1090-6. View on Pubmed
  94. Glynn SA, Schreiber GB, Murphy EL, Kessler D, Higgins M, Wright DJ, Mathew S, Tu Y, King M, Smith JW. Factors influencing the decision to donate: racial and ethnic comparisons. Transfusion. 2006 Jun; 46(6):980-90. View on Pubmed
  95. Barcellos NT, Fuchs SC, Mondini LG, Murphy EL. Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil. Sex Transm Dis. 2006 May; 33(5):302-6. View on Pubmed
  96. Busch MP, Glynn SA, Stramer SL, Orland J, Murphy EL, Wright DJ, Kleinman S. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors. Transfusion. 2006 Mar; 46(3):469-75. View on Pubmed
  97. Carneiro-Proietti AB, Catalan-Soares BC, Castro-Costa CM, Murphy EL, Sabino EC, Hisada M, Galvão-Castro B, Alcantara LC, Remondegui C, Verdonck K, Proietti FA. HTLV in the Americas: challenges and perspectives. Rev Panam Salud Publica. 2006 Jan; 19(1):44-53. View on Pubmed
  98. Gabet AS, Moulés V, Sibon D, Nass CC, Mortreux F, Mauclère P, Gessain A, Murphy EL, Wattel E. Endemic versus epidemic viral spreads display distinct patterns of HTLV-2b replication. Virology. 2006 Feb 5; 345(1):13-21. View on Pubmed
  99. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005 Sep 5; 24(39):6058-68. View on Pubmed
  100. Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Murphy EL, Busch MP. Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply. Med Decis Making. 2005 Sep-Oct; 25(5):571-82. View on Pubmed
  101. Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, Newman B, Lee TH, Chafets DM, Murphy EL. A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis. 2005 May 1; 191(9):1490-7. View on Pubmed
  102. Murphy E, Jacobson S, Franchini G, Taylor GP, Hanchard B, Morgan O, Lairmore M. International Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trials. Retrovirology. 2005; 2:22. View on Pubmed
  103. Jarvis GA, Janoff EN, Cheng H, Devita D, Fasching C, McCulloch CE, Murphy EL. Human T lymphotropic virus type II infection and humoral responses to pneumococcal polysaccharide and tetanus toxoid vaccines. J Infect Dis. 2005 Apr 15; 191(8):1239-44. View on Pubmed
  104. Sanchez AM, Schreiber GB, Nass CC, Glynn S, Kessler D, Hirschler N, Fridey J, Bethel J, Murphy E, Busch MP. The impact of male-to-male sexual experience on risk profiles of blood donors. Transfusion. 2005 Mar; 45(3):404-13. View on Pubmed
  105. Lee TH, Chafets DM, Busch MP, Murphy EL. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J Clin Virol. 2004 Dec; 31(4):275-82. View on Pubmed
  106. Custer B, Tomasulo PA, Murphy EL, Caglioti S, Harpool D, McEvoy P, Busch MP. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion. 2004 Nov; 44(11):1547-54. View on Pubmed
  107. Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Hirschler NV, Murphy EL, Busch MP. Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion. 2004 Oct; 44(10):1417-26. View on Pubmed
  108. Murphy EL, Lee TH, Chafets D, Nass CC, Wang B, Loughlin K, Smith D. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion. J Infect Dis. 2004 Aug 1; 190(3):504-10. View on Pubmed
  109. Roucoux DF, Murphy EL. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev. 2004 Jul-Sep; 6(3):144-54. View on Pubmed
  110. Murphy EL, David Connor J, McEvoy P, Hirschler N, Busch MP, Roberts P, Nguyen KA, Reich P. Estimating blood donor loss due to the variant CJD travel deferral. Transfusion. 2004 May; 44(5):645-50. View on Pubmed
  111. Orland JR, Wang B, Wright DJ, Nass CC, Garratty G, Smith JW, Newman B, Smith DM, Murphy EL. Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort study. Retrovirology. 2004; 1:4. View on Pubmed
  112. Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, Newman B, Ownby HE, Garratty G, Hutching ST, Schreiber GB. Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis. 2004 Jan; 10(1):109-16. View on Pubmed
  113. Murphy EL, Grant RM, Kropp J, Oliveira A, Lee TH, Busch MP. Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients. J Acquir Immune Defic Syndr. 2003 Aug 15; 33(5):655-6. View on Pubmed
  114. Murphy EL, Ownby HE, Smith JW, Garratty G, Hutching ST, Wu Y, Ameti DI. Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study. BMC Pulm Med. 2003 Jul 28; 3:1. View on Pubmed
  115. Glynn SA, Busch MP, Schreiber GB, Murphy EL, Wright DJ, Tu Y, Kleinman SH. Effect of a national disaster on blood supply and safety: the September 11 experience. JAMA. 2003 May 7; 289(17):2246-53. View on Pubmed
  116. Asmuth DM, Kalish LA, Laycock ME, Murphy EL, Mohr BA, Lee TH, Gallarda J, Giachetti C, Dollard SC, van der Horst CM, Grant RM, Busch MP. Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection. Transfusion. 2003 Apr; 43(4):451-8. View on Pubmed
  117. Schreiber GB, Glynn SA, Damesyn MA, Wright DJ, Tu Y, Dodd RY, Murphy EL. Lapsed donors: an untapped resource. Transfusion. 2003 Jan; 43(1):17-24. View on Pubmed